Get started
Author

Kristine M. Zanotti

Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
2023 · Nadeem Abu-Rustum, Catheryn Yashar, et al. · Journal of the National Comprehensive Cancer Network · 574
Duration of Response to Second-Line, Platinum-Based Chemotherapy for Ovarian Cancer: Implications for Patient Management and Clinical Trial Design
2004 · Maurie Markman, Jonathan Markman, et al. · Journal of Clinical Oncology · 220
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
2015 · Anil Belur Nagaraj, Peronne Joseph, et al. · Oncotarget · 196
PDF
Prevention and Management of Antineoplastic-Induced Hypersensitivity Reactions
2001 · Kristine M. Zanotti, Maurie Markman · Drug Safety · 182
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021
2021 · Nadeem R. Abu-Rustum, Catheryn M. Yashar, et al. · Journal of the National Comprehensive Cancer Network · 170
Platinum/taxane‐based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma
2009 · Amanda Nickles Fader, Richard D. Drake, et al. · Cancer · 167
Carboplatin Skin Testing: A Skin-Testing Protocol for Predicting Hypersensitivity to Carboplatin Chemotherapy
2001 · K. M. Zanotti, L. A. Rybicki, et al. · Journal of Clinical Oncology · 156
Expanded Experience With an Intradermal Skin Test to Predict for the Presence or Absence of Carboplatin Hypersensitivity
2003 · Maurie Markman, Kristine Zanotti, et al. · Journal of Clinical Oncology · 149
Diagnosis and Management of Endometrial Hyperplasia
2012 · Amy J. Armstrong, William W. Hurd, et al. · Journal of Minimally Invasive Gynecology · 134
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
2009 · Amanda Nickles Fader, David Starks, et al. · Gynecologic Oncology · 120
The Use of Paclitaxel and Platinum-Based Chemotherapy in Uterine Papillary Serous Carcinoma
1999 · Kristine M. Zanotti, Jerome L. Belinson, et al. · Gynecologic Oncology · 118
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers
2012 · Amanda Nickles Fader, Leigh G. Seamon, et al. · Gynecologic Oncology · 109
Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer
2003 · Maurie Markman, Kenneth Webster, et al. · Gynecologic Oncology · 109
Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies
2012 · Charles A. Kunos, James Brindle, et al. · Frontiers in Oncology · 105
PDF
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
2024 · Nadeem R. Abu-Rustum, Catheryn M. Yashar, et al. · Journal of the National Comprehensive Cancer Network · 101
PDF
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers
2013 · Charles A. Kunos, Tomas Radivoyevitch, et al. · Gynecologic Oncology · 87
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes
2009 · Amanda Nickles Fader, Christa Nagel, et al. · Gynecologic Oncology · 85
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study
2010 · Jean A. Hurteau, Mark F. Brady, et al. · Gynecologic Oncology · 73
The Use of Laparoscopy Simulation to Explore Gender Differences in Resident Surgical Confidence
2017 · Rebecca L. Flyckt, Eliza E. White, et al. · Obstetrics and Gynecology International · 69
PDF
Management of the Adnexal Mass
2011 · James H. Liu, Kristine M. Zanotti · Obstetrics and Gynecology · 68
A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix
2015 · Charles Kunos, Wei Deng, et al. · International Journal of Gynecological Cancer · 66
Lymphovascular Space Invasion (LVSI) Is an Isolated Poor Prognostic Factor for Recurrence and Survival Among Women With Intermediate-to High-Risk Early-Stage Endometrioid Endometrial Cancer
2013 · Lori E. Weinberg, Charles A. Kunos, et al. · International Journal of Gynecological Cancer · 65
Treatment of gynecologic cancers in pregnancy.
2000 · K M Zanotti, J L Belinson, et al. · PubMed · 64
The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis
2019 · Sarah E. Taylor, Caitlin M. O'Connor, et al. · Cancer Research · 60
Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials
2004 · M MARKMAN, K WEBSTER, et al. · Gynecologic Oncology · 58
Works count: 206
Citation count: 4,059
H-index: 32
I10-index: 52
Year
Topic
Type